Morphologic and genomic characterization of circulating tumor cells in patients with metastatic colorectal cancer treated with combinational treatment of andecaliximab, bevacizumab and chemotherapy.
Recombinant human ACE2 as a novel biotherapeutic for the treatment of patients with cancer. Background: EGFR-TKI is one of the most important treatments of NSCLC patients, but not all patients ...
A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results